MbrlCatalogueTitleDetail

Do you wish to reserve the book?
2022-RA-950-ESGO Low grade and high grade serous ovarian cancer: comparison of surgical outcome after secondary cytoreductive surgery
2022-RA-950-ESGO Low grade and high grade serous ovarian cancer: comparison of surgical outcome after secondary cytoreductive surgery
Hey, we have placed the reservation for you!
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
2022-RA-950-ESGO Low grade and high grade serous ovarian cancer: comparison of surgical outcome after secondary cytoreductive surgery
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Title added to your shelf!
Title added to your shelf!
View what I already have on My Shelf.
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
2022-RA-950-ESGO Low grade and high grade serous ovarian cancer: comparison of surgical outcome after secondary cytoreductive surgery
2022-RA-950-ESGO Low grade and high grade serous ovarian cancer: comparison of surgical outcome after secondary cytoreductive surgery

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
How would you like to get it?
We have requested the book for you! Sorry the robot delivery is not available at the moment
We have requested the book for you!
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
2022-RA-950-ESGO Low grade and high grade serous ovarian cancer: comparison of surgical outcome after secondary cytoreductive surgery
2022-RA-950-ESGO Low grade and high grade serous ovarian cancer: comparison of surgical outcome after secondary cytoreductive surgery
Journal Article

2022-RA-950-ESGO Low grade and high grade serous ovarian cancer: comparison of surgical outcome after secondary cytoreductive surgery

2022
Request Book From Autostore and Choose the Collection Method
Overview
Introduction/BackgroundRetrospective series have shown secondary cytoreductive surgery (SCS) improves oncological outcomes in recurrent low-grade serous ovarian cancer (LGSOC), a relatively chemoresistant subtype. We aim to describe surgical procedures and complications, for this subset of patients compared to the high-grade serous ovarian cancer (HGSOC) counterpart.MethodologyThis is a retrospective single-institution study on patients affected by platinum sensitive recurrent LGSOC and HGSOC undergoing SCS between 2009–2021. Patients were matched for clinical characteristics such as age, stage, residual tumor at first surgery, and platinum-sensitivity. Complexity of surgery was assessed by Aletti’s score and post-operative complications by Clavien Dindo classification.ResultsFifty-two patients undergoing SCS were included in our analysis. Patients’ characteristics are described in table 1. Recurrence was mainly localized in the peritoneum in both groups but reached a statistically significant higher rate for the diaphragm (38.5% vs 11.5%, p=0.026) and the small bowel (53.8% vs 7.7%, p<0.001) in LGSOC compared to HGSOC counterpart. On the contrary, HGSOC showed a higher rate of nodal recurrences than LGSOC (38.5% vs 23.1%, p= 0.18). Overall, surgical complexity (Aletti’s score group >1) was higher in LGSOC than in HGSOC patients (65.4% vs 37.5%; p=0.045), with LGSOC cases undergoing multiple bowel resections more frequently than HGSOC (26.9% vs 3.8%; p=0.025). Median EBL was also higher in LGSOC than in HGSOC patients (400 vs 100 ml; p=0.036). Twenty-five patients achieved optimal residual disease after SCS in both groups (p=0.75) with no statistically significant differences in term of post-operative complications.Abstract 2022-RA-950-ESGO Table 1Patient’s characteristics, surgical and complication dataConclusionSCS in LGSOC patients is associated with higher complexity, multiple bowel resections, and higher median estimated blood loss than in HGSOC. However, the comparable rate of post-operative complications confirms the role of SCS in this group of patients.
Publisher
BMJ Publishing Group Ltd,Elsevier Inc,Elsevier Limited